Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

507 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis.
Radlinger B, Ress C, Folie S, Salzmann K, Lechuga A, Weiss B, Salvenmoser W, Graber M, Hirsch J, Holfeld J, Kremser C, Moser P, Staudacher G, Jelenik T, Roden M, Tilg H, Kaser S. Radlinger B, et al. Among authors: tilg h. Diabetologia. 2023 Apr;66(4):754-767. doi: 10.1007/s00125-022-05851-x. Epub 2022 Dec 16. Diabetologia. 2023. PMID: 36525084 Free PMC article.
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us.
Grabherr F, Grander C, Effenberger M, Schwärzler J, Tilg H. Grabherr F, et al. Among authors: tilg h. Ther Adv Endocrinol Metab. 2022 Nov 22;13:20420188221139101. doi: 10.1177/20420188221139101. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 36439029 Free PMC article. Review.
The pathophysiology of MASLD: an immunometabolic perspective.
Schwärzler J, Grabherr F, Grander C, Adolph TE, Tilg H. Schwärzler J, et al. Among authors: tilg h. Expert Rev Clin Immunol. 2024 Apr;20(4):375-386. doi: 10.1080/1744666X.2023.2294046. Epub 2023 Dec 27. Expert Rev Clin Immunol. 2024. PMID: 38149354 Review.
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ.
Grander C, Meyer M, Steinacher D, Claudel T, Hausmann B, Pjevac P, Grabherr F, Oberhuber G, Grander M, Brigo N, Jukic A, Schwärzler J, Weiss G, Adolph TE, Trauner M, Tilg H. Grander C, et al. Among authors: tilg h. JHEP Rep. 2023 Aug 3;5(11):100872. doi: 10.1016/j.jhepr.2023.100872. eCollection 2023 Nov. JHEP Rep. 2023. PMID: 37818230 Free PMC article.
Sucralose and Erythritol - Not Too Sweet.
Tilg H, Adolph TE. Tilg H, et al. N Engl J Med. 2023 Aug 31;389(9):859-861. doi: 10.1056/NEJMcibr2303516. N Engl J Med. 2023. PMID: 37646685 No abstract available.
NASH drug treatment development: challenges and lessons.
Tilg H, Byrne CD, Targher G. Tilg H, et al. Lancet Gastroenterol Hepatol. 2023 Oct;8(10):943-954. doi: 10.1016/S2468-1253(23)00159-0. Epub 2023 Aug 16. Lancet Gastroenterol Hepatol. 2023. PMID: 37597527 Review.
Apelin and the gut microbiome: Potential interaction in human MASLD.
Effenberger M, Grander C, Hausmann B, Enrich B, Pjevac P, Zoller H, Tilg H. Effenberger M, et al. Among authors: tilg h. Dig Liver Dis. 2023 Dec 11:S1590-8658(23)01041-1. doi: 10.1016/j.dld.2023.11.023. Online ahead of print. Dig Liver Dis. 2023. PMID: 38087672
507 results